Literature DB >> 23293555

Novel treatment of fecal incontinence with an injectable biocompatible tissue bulking agent.

Mitchell Bernstein1.   

Abstract

Entities:  

Year:  2012        PMID： 23293555      PMCID： PMC3533221     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Diagnosis and management of fecal incontinence. American College of Gastroenterology Practice Parameters Committee.

Authors:  Satish S C Rao
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

Review 2.  Treatment options for fecal incontinence.

Authors:  W E Whitehead; A Wald; N J Norton
Journal:  Dis Colon Rectum       Date:  2001-01       Impact factor: 4.585

3.  Submucosal injection of stabilized nonanimal hyaluronic acid with dextranomer: a new treatment option for fecal incontinence.

Authors:  Johan Danielson; Urban Karlbom; Ann-Cathrine Sonesson; Tomas Wester; Wilhelm Graf
Journal:  Dis Colon Rectum       Date:  2009-06       Impact factor: 4.585

4.  Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial.

Authors:  Wilhelm Graf; Anders Mellgren; Klaus E Matzel; Tracy Hull; Claes Johansson; Mitch Bernstein
Journal:  Lancet       Date:  2011-03-19       Impact factor: 79.321

5.  An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence.

Authors:  Giuseppe Dodi; Johannes Jongen; Fernando de la Portilla; Manoj Raval; Donato F Altomare; Paul-Antoine Lehur
Journal:  Gastroenterol Res Pract       Date:  2010-12-27       Impact factor: 2.260
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.